m-PGES-1 inhibitors (Merck Frosst)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namem-PGES-1 inhibitors (Merck Frosst)

Drug Alias NameMK-886 derivatives (Merck Frosst)m-PGES-1 inhibitors (Merck & Co)prostaglandin E2 synthase inhibitors (Merck & Co)prostaglandin E2 synthase inhibitors (Merck Frosst)MK-886 derivatives (Merck & Co) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstaglandin E synthase inhibitors

TargetsProstaglandin E synthase

Therapy Area/IndicationsPainInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMerck Canada Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Canada Inc

Active IndicationsN/A

Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A